Posts by Brian Westerlind
New FDA Report on the State of Pharmaceutical Quality Fiscal Year 2020
By Mark Land, AAHP President The US FDA’s Office of Pharmaceutical Quality published its 2020 report on the state of pharmaceutical quality on August 17, 2021. Homeopathic drug products…
Read MoreHomeopathy’s Path Ahead: 5 Ways We’re Moving the Needle Together
A glance at AAHP and HPCUS’ multi-year, industry-wide initiative to clarify ambiguities in homeopathic manufacturing. Homeopathy’s path forward is a collective effort between manufacturers, scientists, homeopathic practitioners, and regulators.…
Read MoreThe Importance of AAHP’s 2021 Summit
Implementing HPUS Guidelines for FDA Compliance, Part 2 By Mark Land, AAHP President AAHP’s newsletter editor asked me to write an article explaining the importance of the upcoming…
Read MoreInternational Coalition of Homeopathic Associations
By Mark Land, AAHP President David Skinner of the Canadian Homeopathic Pharmaceutical Association recently wrote that there is a need for an international coalition of homeopathic associations. He makes this…
Read MoreHomeopathic Pharmacopoeia Convention Activities 2020–2021
In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted…
Read MoreFDA Eyes Improvements to Nonprescription Drug Labeling
What impact will that have on your products? The top line: Two years after issuing draft guidance on “innovative” nonprescription drug labeling, FDA is again thinking about potential improvements to…
Read MoreThe Environment for Homeopathy in Canada
By David Skinner, Association Manager, Canadian Homeopathic Pharmaceutical Association In the global context, Canada is a very small market, but the dynamics are no different than in other large markets…
Read MoreAAHP Disclaimer: Continuing to Deliver Value After Five Years
The AAHP disclaimer, “Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated,” benefits from the best support among disclaimers I have seen – Use It! …
Read MoreAAHP Disclaimer Helps Win Two Lawsuits
Advancing Goal of Informing Consumers & Protecting Sellers By Alvin J. Lorman, Association Counsel If you’ve wondered whether the American Association of Homeopathic Pharmacists’ (AAHP) recommended consumer label…
Read MorePoison Control Center Statistics on Homeopathy
What’s Your Company’s Safety Statistics? When FDA announced its public hearing on homeopathy, the agency cited 10,311 reported poison exposure cases related to “homeopathic agents” in the 2012 American…
Read More